Longaeva Partners »

Jade Biosciences shares owned by Longaeva Partners

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 79k 22.22

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Jade Biosciences

FMR
Jupiter Topco
Fairmount Funds Management
RA Capital Management
VR Adviser
Henderson Group
Bellevue Group
Paradigm Biocapital Advisors
BlackRock
Franklin Resources
Vanguard Capital Management
Adage Capital Partners GP
Polar Capital Holdings
Avidity Partners Management
Remedium Capital Partners

View all funds holding Jade Biosciences